Daroogooyinkaasi waxay isbaddalayaan Jirrooyinka Wajaho
Biyoolajiyadu waa daroogo laga sameeyey maadooyin adag oo la soo saaray iyadoo la isticmaalayo sheyga nool, dhirta, ama unugyada xayawaanka. Biyooloji badan ayaa la soo saaraa iyadoo la adeegsanayo tiknoolajiyada DNA-da ee dib u habaynta Waxaa mararka qaarkood loo yaqaan 'biopharmaceuticals or drugs biological'.
Cilmi-nafsiyadu waxay is-beddeleen daaweynta cuduro badan oo culus iyo waliba daawooyinka yaryar-yar-yar-yar-yar ee ka sameysan goobaha iibka ugu sarreeya. Rheumatoid arthritis, kansarrada qaarkood, iyo sonkorowga ayaa leh tirada ugu badan ee daaweynta nafsaaniga ah ee gaarka ah. Biyoolojiyadu waxay bedelayaan qaababka takhaatiirta uula dhaqmaan shuruudaha guud ee shakhsiyaadka u horseeday sanado badan.
Cilmi-nafsiga guud
Inkasta oo daroogooyinka intooda badani yihiin kiimikooyin laga soo saaro kiimikooyinka kale, bayoolojiga ayaa aad u qaali ah sababtoo ah habka wax soo saarka adag. Sababtoo ah kharashkooda sarreeya, waxaa jira dalab weyn oo loogu talagalay noocyada guud ee daawooyinka bayoolajiga, gaar ahaan tobanka hoos ku taxan. Qaar badan oo ka mid ah shirkadaha dawooyinka ayaa ku mashquulsan xaq u leh inay soo saaraan qaybo guud. Si kastaba ha noqotee, sababta oo ah way adag tahay in la soo saaro, waxaa jira walaac ah oo ku saabsan awooda lagu soo saaro caanaha labadaba si ammaan ah iyo kalsooni leh.
Sare 10 Biyooloji sare
Tobankii daawo ee hoos ku taxan ayaa si weyn uga gudubtay qeexitaanka lacagta "blockbuster" kaas oo u xilsaaray daroogada markii uu soo saaray wax ka badan $ 1 bilyan sannadkii.
Sannadka 2015, bayoolojiyadu waxay bilaabeen tartan ka yimaada biosimilars , ama biogenerics, markii Rituximab ay soo saartay by Pharmaceuticals IDEC sida magaca IDEC-C2B8 . [1] Patentka Maraykanka ayaa la soo saaray 1998-kii wuxuuna dhacay sannadkii 2015-kii. Humira waxay lumisay ilaalinteedii patent-kii sannadka 2016-ka iyo Remicade waxay lumin doontaa ilaalinteeda sannadka 2018.
Tirooyinka hoos ku qoran waxay ku qoran yihiin taariikhaha ugu dambeeya ee la heli karo ee loogu talagalay alaab kasta.
01 Humira
Tilmaamaha: Rheumatoid arthritis, cudurka psoriasis, cudurka Crohn, caarada ulcerative, spondylitis ankylosing; xanuunka psoriasis ee arthritis-ka, cudurka cagaarshowga arthritis-ka ee jilicsan
Soo saaraha: AbbVie, Abbott Laboratories ayaa lafdhabar u ah
Sales Global ee 2015: $ 14 bilyan
Magaca guud: Adalimumab
Taariikhda la bilaabay: 2002
02 Qaadashada
Tilmaamaha: Rheumatoid arthritis, Crohn's cudurada, stonkyling spondylitis, psoriasis arthritis, cudurka psoriasis, ulcerative colitis
Soo saaraha: Johnson & Johnson / Merck & Co.
Sales Global ee 2015: $ 5.78 bilyan
Magaca guud: Infliximab
Billow taariikh: 1998
03 Rituxan
Astaamaha: Lymphoma Non-Hodgkins, lymphocytic leukemia, rheumatoid arthritis
Soo saaraha: Roche
Sales Global ee 2015: $ 7.32 bilyan
Magaca guud: Rituximab
Taariikhda la bilaabay: 1997
04 Enbrel
Astaameynta: Rheumatoid arthritis, psoriasis-da, cudurka psoriasis ee arthritis
Soo saaraha: Pfizer / Amgen
Sales Global ee 2016: $ 23 bilyan
Magaca guud: Etanercept
Billow taariikh: 1998
05 Lantus
Indhaha: Sonkorowga
Soo saaraha: Sanofi
Sales Global ee 2015: $ 6.98 bilyan
Magaca guud: Insulin glargine [rDNA origin] cirbadeynta
Taariikhda la bilaabayo: 2000
06 Avastin
Astaameynta: Naas-nuujin, midabo, kelyo, unug aan-yareyn, glioblastoma, kansarka ugxan-badan
Soo saaraha: Roche
Sales Global ee 2015: $ 6.95 bilyan
Magaca guud: Bevacizumab
Taariikhda la bilaabay: 2004
07 Hanashada
Indhaha: HER2 + kansarka naasaha
Soo saaraha: Roche
Sales Global ee 2015: $ 6.59 bilyan
Magaca guud: Trastuzumab
Billow taariikh: 1998
08 Neulasta
Soo saaraha: Amgen
Sales Global ee 2016: $ 4.6 bilyan
Magaca guud: Pegfilgrastim
Taariikhda la bilaabay: 2002
09 Lucentis
Astaameynta: Cilad-xumada macquulka ah ee da'da
Soo saaraha: Roche, Novartis
Sales Global ee 2015: $ 4.2 bilyan
Magaca guud: Ranibizumab
Taariikhda la bilaabay: 2006
10 Avonex
Gemany's Fraunhofer Institute for Interfacial Engineering iyo Biotechnology IGB iyo CinnaGen Company ayaa isku duubay Interferon beta-1a tan iyo 2006dii daroogada ayaa loo iibiyey CinnoVex, oo ah biosimilar, Iran.
Astaamaha: Cudurka Cagaarshowga (MS)
Soo saaraha: Biogen Idec
Sales Global ee 2014: $ 3 bilyan
Magaca guud: Interferon beta-1a
Taariikhda la bilaabay: 1996